- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Rivaroxaban (pe) – March 2013
Rivaroxaban (PE), tablets, 15mg and 20mg, Xarelto®
Last updated
8 November 2023